Skip to content
Purple Wave

Breast Solutions

Advancing breast imaging by transforming screening and diagnostic care pathways with end-to-end, multi-modality, AI-powered solutions.

Book a demo
Breast Suite
Purple Wave

Explore the industry’s most comprehensive integrated portfolio of AI-powered suites of solutions at the European Congress of Radiology.

4 - 8 March, 2026
Vienna, Austria
Book a demo

Enhanced efficiency and accuracy in breast cancer detection

Purple Wave

Automated localization of regions of interest and degree of suspicion on both 2D2 & 3D images, incorporating the use of priors

Automated density classification with a patient-centric, accurate density assessment of 2D2 or 3D mammograms to support objective diagnostic decisions.

Reveals comorbidities by automatically flagging breast arterial calcifications on screening mammograms with slice-level visualization.

Identifies high risk of developing breast cancer in up to 5 years, using image-base analysis of the mammogram.

Mammo Dx Mammo Density BAC Mammo Risk
Purple Wave

Improved cancer detection rate with second reader workflow 4

 
DM (2D)

DM (2D)

9.4% Increased CDR 5
DBT (3D)

DBT (3D)

21% Increased CDR 6
Safeguard Review Workflow

Safeguard Review Workflow 4

A multimodality breast imaging solution where AI-powered mammography and ultrasound work together to deliver more complete, confident diagnosis

Mammography Insights 8

Built-in quality analytics that enhance mammography quality, and makes compliance easier.

· Tech Lead dashboard & report with group & individual performance to support improvement plan
· Tools for monitoring MQSA compliance and ACR audits
· Technologist interface with individual audit, criteria score and explanation to support performance improvement

Mammography Insights

Breast Ultrasound 7

Book a demo
Breast Ultrasound

Automated lesion detection and characterization in line with ACR BI-RADs including priors comparison.

Autogenerated ultrasound worksheets improving sonographer’s workflow efficiency.

Built-in Auto Draft, pre-populating key findings and impressions for efficient reporting workflow.

Purple Wave

Clinical impact at scale

Explore Clinical Evidence

21%

increased cancer detection rate (CDR)6

23%

more cancers detected in women with dense breasts6

37%

reduction10 in breast ultrasound interpretation time

Specialist level care

achieved by a group of general radiologists9

Purple Wave
quotes

Real voices.
Real impact.

Jason R. Sinner M.D.
White Wave

Jason R. Sinner M.D.

Medical Director, RadNet/BRMG

“It has made me considerably more efficient due to decreased lag between loading patient studies, in particular as it relates to breast tomography where I can instantly review the current study along with multiple prior exams.”

Dr. Jacqueline Holt
White Wave

Dr. Jacqueline Holt

Medical Director, Women’s Imaging, Delaware Imaging Network, RadNet

“Breast Solutions help me read smarter and more efficiently. It allows me to sort and prioritize mammograms most likely to have cancer in them and draws my attention to what really matters in each image.”

Purple Wave
CT scan

Radiology AI Suite
One Platform.
Enterprise-wide Impact​

Bringing together the broadest portfolio of native clinical AI solutions, intelligent workflow orchestration, and insights on on one cloud-enabled platform. It spans across multiple clinical areas across most of core imaging modalities – MR, CT, X-Ray, mammography and ultrasound – covering triage, detection, assessment, risk prediction and monitoring, with AI findings delivered directly into the worklist, viewer and reporting tools.

For health systems and imaging networks, it replaces a fragmented landscape of single-purpose AI tools with one platform, one partner, one intelligent experience.

Discover Radiology AI Suite​
[1] Mammo Dx formerly known as ProFound Pro, retains the FDA cleared capabilities of ProFound Pro and serves as the foundation for ongoing innovation, with additional features and enhancements being introduced over time.
[2] 2D is only supported in EU. Not available in US yet.
[3] 2D is only supported in EU. Not available in US yet. FDA Pending.
[4] Safeguard Review Workflow comprises of multiple DeepHealth Breast solutions.
[5] Lee et al. "National Performance Benchmarks for Screening Digital Breast Tomosynthesis: Update from the Breast Cancer Surveillance Consortium." Radiology. Apr 2023 
[6] Louis et al. "Equitable impact of an AI-driven breast cancer screening workflow in real-world US-wide deployment." Nature Health. Nov 2025.
[7] Breast Ultrasound is as See-Mode Augmented Reporting Tool, Breast (SMART-B) by See-Mode and distributed by DeepHealth Inc. 
[8] DeepHealth Mammo Insights is manufactured by Aquila, Inc. and distributed by DeepHealth, Inc.
[9] McCabe et al. “Multistage AI-Driven Workflow Improves General Radiologist Screening Mammography Performance to the Level of Fellowship-Trained Breast Imagers: Real-world Evidence in >500,000 Patients.” RSNA Chicago. 2025.
[10] Based on data from MRMC study submitted to FDA for 510(k) clearance K260303.

Disclaimers: Breast Solutions comprises multiple applications including Mammo Dx , Mammo Density, Safeguard Review, Mammo Risk, BAC, Breast Ultrasound, Mammography Insights and DeepHealth Viewer. DeepHealth Viewer is Manufactured as eRAD PACS by eRAD and distributed by DeepHealth, Inc. DeepHealth Mammo Insights is manufactured by Aquila, Inc. and distributed by DeepHealth, Inc. DeepHealth Breast Ultrasound is manufactured as See-Mode Augmented Reporting Tool, Breast (SMART-B) by See-Mode Technologies Ltd. and distributed by DeepHealth Inc. Any claims made about Breast Solutions may reference claims associated with its individual components.Not all products and functionalities are commercially available in all countries.